Business November 22, 2020
Regeneron obtains FDA emergency use authorization for its COVID-19 antibody treatment
The U.S. Food and Drug Administration (FDA) granted Regeneron Pharmaceuticals (NASDAQ; REGN) an emergency use authorization (EUA) for its COVID-19…